21
TITLE: Current advances in targeted therapies for metastatic gastric cancer: improving patient care
AUTHORS: Pedro Nazareth Aguiar; Thiago Pimentel Muniz; Raelson Rodrigues Miranda; Hakaru Tadokoro; Nora Manoukian Forones; Ines de Paula Monteiro; Pedro Castelo Branco; Yelena Y Janjigian; Ramon Andrade de Mello;
PUBLISHED: 2016, SOURCE: FUTURE ONCOLOGY, VOLUME: 12, ISSUE: 6
INDEXED IN: Scopus WOS CrossRef
22
TITLE: Are there, or shall we discover, biomarkers to guide PD-1 inhibition?
AUTHORS: Paolo A Ascierto; Ramon Andrade de Mello;
PUBLISHED: 2016, SOURCE: IMMUNOTHERAPY, VOLUME: 8, ISSUE: 6
INDEXED IN: Scopus WOS CrossRef
23
TITLE: TG4010 immunotherapy: a novel weapon against advanced non-small cell lung cancer?
AUTHORS: Ramon Andrade de Mello;
PUBLISHED: 2016, SOURCE: ANNALS OF TRANSLATIONAL MEDICINE, VOLUME: 4, ISSUE: 9
INDEXED IN: Scopus WOS CrossRef
24
TITLE: A pooled analysis of nivolumab for the treatment of advanced non-small-cell lung cancer and the role of PD-L1 as a predictive biomarker
AUTHORS: Aguiar, PN; Santoro, IL; Tadokoro, H; Lopes, GD; Filardi, BA; Oliveira, P ; Castelo Branco, P; Mountzios, G; de Mello, RA;
PUBLISHED: 2016, SOURCE: Immunotherapy, VOLUME: 8, ISSUE: 9
INDEXED IN: Scopus WOS CrossRef
25
TITLE: Outcomes of allogeneic stem cell transplantation among patients with acute myeloid leukemia presenting active disease: Experience of a single European Comprehensive Cancer Center  Full Text
AUTHORS: Ramon Andrade B Bezerra de Mello; Carlos Pinho Vaz; Rosa Branca; Fernando Campilho; Maria Rosales; Susana Roncon; Antonio Campos Junior;
PUBLISHED: 2016, SOURCE: REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, VOLUME: 62, ISSUE: 7
INDEXED IN: WOS
26
TITLE: EGFR and EML4-ALK Updated Therapies in Non-Small Cell Lung Cancer
AUTHORS: Ramon Andrade de Mello; Davi J J Liu; Pedro N Aguiar; Hakaru Tadokoro;
PUBLISHED: 2016, SOURCE: RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, VOLUME: 11, ISSUE: 4
INDEXED IN: WOS
27
TITLE: Targeting HER family in HER2-positive metastatic breast cancer: potential biomarkers and novel targeted therapies
AUTHORS: Ines de Paula Costa Monteiro; Pedro Madureira; Alessandro de Vasconscelos; Daniel Humberto Pozza ; Ramon Andrade de Mello;
PUBLISHED: 2015, SOURCE: PHARMACOGENOMICS, VOLUME: 16, ISSUE: 3
INDEXED IN: Scopus WOS CrossRef: 21
28
TITLE: Nivolumab for advanced squamous cell lung cancer: what are the next steps?  Full Text
AUTHORS: Ramon Andrade de Mello; Ines Pousa; Deolinda Pereira;
PUBLISHED: 2015, SOURCE: LANCET ONCOLOGY, VOLUME: 16, ISSUE: 3
INDEXED IN: Scopus WOS CrossRef
29
TITLE: Treating operable patients with gastric cancer: Macdonald's protocol versus adjuvant chemotherapy
AUTHORS: Pedro Nazareth Aguiar; Hakaru Tadokoro; Nora Manoukian Forones; Ramon Andrade de Mello;
PUBLISHED: 2015, SOURCE: FUTURE ONCOLOGY, VOLUME: 11, ISSUE: 16
INDEXED IN: Scopus WOS CrossRef
30
TITLE: MMR deficiency may lead to a high immunogenicity and then an improvement in anti-PD-1 efficacy for metastatic colorectal cancer
AUTHORS: Pedro Nazareth Aguiar; Hakaru Tadokoro; Nora Manoukian Forones; Ramon Andrade de Mello;
PUBLISHED: 2015, SOURCE: IMMUNOTHERAPY, VOLUME: 7, ISSUE: 11
INDEXED IN: Scopus WOS CrossRef
Page 3 of 5. Total results: 50.